Comparative genomic analyses of Mycoplasma hyopneumoniae pathogenic 168 strain and its high-passaged attenuated

Wei Liu1, Shaobo Xiao, Mao Li

  • 1Division of Animal Infectious Diseases, State Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, People's Republic of China.

BMC Genomics
|February 7, 2013
PubMed
Abstract

Insights

Comparative genomics revealed genetic variations in Mycoplasma hyopneumoniae, identifying novel virulence determinants and providing insights into porcine enzootic pneumonia (EP) pathogenesis and vaccine development.

Area of Science:

  • Veterinary Microbiology
  • Genomics
  • Pathogenesis

Background:

  • Mycoplasma hyopneumoniae causes porcine enzootic pneumonia (EP), a significant economic concern in the swine industry.
  • Understanding the genetic basis of M. hyopneumoniae virulence is crucial for disease control.

Purpose of the Study:

  • To identify virulence-associated genetic determinants of M. hyopneumoniae.
  • To compare the whole genome sequences of a virulent strain (168) and its attenuated high-passage derivative (168-L).

Main Methods:

  • Whole genome sequencing of M. hyopneumoniae strains 168 and 168-L.
  • Comparative genomic analysis, including identification of insertions, deletions, and single nucleotide variations.
  • Analysis of variants affecting coding sequences (CDSs) and comparison with known virulence factors.

Main Results:

  • The attenuated strain 168-L genome showed high similarity to strain 168 but was smaller due to indels and SNVs.
  • Many identified variants affected CDSs, including known virulence determinants like mycoplasma adhesins, cell envelope proteins, and secreted proteins.
  • Mutations in metabolism and growth-related genes, as well as in repeat motifs, were also observed and may contribute to attenuated virulence.

Conclusions:

  • Comparative genomics elucidated the virulence attenuation mechanism of M. hyopneumoniae.
  • The study identified both known and novel virulence-associated CDSs, offering a foundation for further research.
  • Findings will aid future investigations into M. hyopneumoniae pathogenesis and the development of new vaccines.